Capsulution NanoScience AG:Innovative Technology Company Triples Turnover
Berlin (February 3, 2004) - The Berlin-based technology company Capsulution NanoScience AG can look back onto a very successful year after it tripled turnovers during the second half of 2003. According to a preliminary balance at the end of the second half of last year the Company was able to generate operational profits of some 45,000 euros compared with operational losses of some 585,000 euros during the first half of 2003. Following the company's shake-up that was started last summer the overall performance during the financial year 2003 has been considerably better than expected.

Based on the continuing development of innovative nanoproducts for numerous industrial applications and thanks to the acquisition of several renowned partners and clients during the course of last year Capsulution expects another substantial increase in turnovers for the current year and looks forward to breaking-even.

Alexander Herrmann, Chief Financial Officer of the Berlin-based company, commented very optimistically on the new financial year: "Despite our primary goal of becoming profitable we are continuing on the path of our vision, to apply our proprietary resources in laying the foundations for the introduction of our technology to new areas of application. In this respect we are very confident that also in 2004 we will be able to convince new industry partners of the versatility and benefits of our nanotechology. Additionally we are committed to offering interested financiers continual opportunities to invest in the successful progression of our technology and to participate in the value creation of our company."

244 words/1,598 characters


About Capsulution NanoScience AG:
Capsulution NanoScience AG develops innovative nano- and micron-sized capsules. The company applies its proprietary so-called LBL-Technology®. Based on their minute size, their functionality and their highly reproducible production process the capsules can be used for a multitude of different applications. Accordingly, the precisely sized capsules (500 nm to 50 µm) can be made to function in a manner to suit the intended application, and can be given the appropriate biochemical, electrical, optical and magnetic properties as required by the customer. The capsules can be applied for the delivery of drugs, in cosmetic products, and in diagnostics. Today, the Berlin-based company has 16 highly qualified employees. Amongst Capsulution's clients and partners are key industrial players such as Bayer AG, Gelita, SCA Hygiene Products, Cognis, OctoPlus and other renowned companies.


Downloads: Text as RTF in "Presse Pool": www.biocommunications.net 


Contact:
Capsulution NanoScience AG
Alexander Herrmann (CFO)
Volmerstr. 7b
D- 12489 Berlin, Germany
Tel.: +49-(0)30-63923627
Fax.: +49-(0)30-63923601
eMail: alexander.herrmann@capsulution.com 
Web: www.capsulution.com 


© BIOCOMMUNICATIONS.net GmbH, Brunnenstr. 128, D-13355 Berlin, Germany - Reprint free of charge, please supply copy